Market Capitalization of Concord Drugs (CONCORD)
Market Cap
₹86.94 Cr
$9.66M USD
As of November 2025
Concord Drugs ranks 3137 out of 5115 companies based on market capitalization in our dataset.
Market capitalization reflects the total value of a company's outstanding shares. It's a key metric journal users rely on to assess company size, compare across sectors, and track valuation trends
over time.
Use this data point within your Tickjournal entries to log how valuation levels relate to your trade timing or long-term positioning.
For current performance insights, view the Concord Drugs share price page .
Use this data point within your Tickjournal entries to log how valuation levels relate to your trade timing or long-term positioning.
For current performance insights, view the Concord Drugs share price page .
Current Price
₹73.92
Outstanding Shares
1.18 Cr
Market Cap Rank
#3137
Top Percentile
38.7%
Market Cap History of Concord Drugs (Last 10 Years)
Related Pages for Concord Drugs
Additional stock information and data for CONCORD
End of Year Market Cap History
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹86.94 Cr
$9.66M USD
|
₹73.92 | BSE | -10.38% |
| 2025 |
₹97.01 Cr
$10.78M USD
|
₹82.48 | BSE | +118.78% |
| 2024 |
₹44.34 Cr
$4.93M USD
|
₹37.70 | BSE | -36.87% |
| 2023 |
₹70.24 Cr
$7.80M USD
|
₹59.72 | BSE | +83.47% |
| 2022 |
₹38.28 Cr
$4.25M USD
|
₹32.55 | BSE | +1.24% |
| 2021 |
₹37.81 Cr
$4.20M USD
|
₹32.15 | BSE | +40.39% |
| 2020 |
₹26.93 Cr
$2.99M USD
|
₹22.90 | BSE | +52.67% |
| 2019 |
₹17.64 Cr
$1.96M USD
|
₹15.00 | BSE | -33.63% |
| 2018 |
₹26.58 Cr
$2.95M USD
|
₹22.60 | BSE | -29.37% |
| 2017 |
₹37.64 Cr
$4.18M USD
|
₹32.00 | BSE | -34.69% |
| 2016 |
₹57.63 Cr
$6.40M USD
|
₹49.00 | BSE | -17.72% |
| 2015 |
₹70.04 Cr
$7.78M USD
|
₹59.55 | BSE | - |
Market Cap Data Sources
Tickjournal (INR)
₹86.94 Cr
Tickjournal (USD)
$9.66M
Price Source
BSE
USD to INR Rate
₹90.00